Indeed, MMP-7 is now considered one of the most promising prognostic biomarkers in IPF, with circulating levels correlating with disease severity, as assessed by FVC and DFCO, and with survival, as reported in several studies (Inoue et al., 2020). This evidence concerns the gene MMP7 and idiopathic pulmonary fibrosis.